bluebird bio Inc. (NASDAQ: BLUE) Stock Information | RedChip

bluebird bio Inc. (NASDAQ: BLUE)


$8.4900
-0.0100 ( +2.30% ) 0.3K

bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

Market Data


Open


$8.4900

Previous close


$8.5000

Volume


0.3K

Market cap


$82.64M

Day range


$8.1700 - $8.2990

52 week range


$5.8000 - $38.4000

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 May 29, 2024
nt Quarterly Reports 1 May 15, 2024
8-k 8K-related 14 May 09, 2024
8-k 8K-related 15 May 03, 2024
8-k 8K-related 14 Apr 26, 2024
8-k 8K-related 13 Apr 16, 2024
8-k 8K-related 15 Mar 26, 2024
nt Quarterly Reports 1 Mar 26, 2024
8-k 8K-related 13 Mar 18, 2024
4 Insider transactions 2 Mar 05, 2024

Latest News